← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Aadi, Llc
Pacific Palisades, CA
$3,564,498
Total funding
2
Grants
Funding over time
peak $924.7K · FY2012–20$1M$750K$500K$250K$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
FDA$1,998,524 · 1
NIH$1,565,974 · 1
By mechanism
R01$1,998,524 · 1
R42$1,565,974 · 1
Investigators at Aadi, Llc
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Investigation of a nanoparticle albumin-bound mTOR inhibitor, nab-rapamycin for t$924,745
R42 · FY2015 · CA
Phase 2 study of ABI-009 Treatment of Advanced PEComa-IND 125669, 7/13/2015$499,631
R01 · FY2017 · FD
Phase 2 study of ABI-009 Treatment of Advanced PEComa-IND 125669, 7/13/2015$499,631
R01 · FY2018 · FD
Phase 2 study of ABI-009 Treatment of Advanced PEComa-IND 125669, 7/13/2015$499,631
R01 · FY2019 · FD
Phase 2 study of ABI-009 Treatment of Advanced PEComa-IND 125669, 7/13/2015$499,631
R01 · FY2020 · FD
Investigation of a nanoparticle albumin-bound mTOR inhibitor, nab-rapamycin for t$472,301
R42 · FY2012 · CA
Investigation of a nanoparticle albumin-bound mTOR inhibitor, nab-rapamycin for t$168,928
R42 · FY2013 · CA